Correction: DanCann Pharma A/S publishes Annual Report 2021
Correction of the previously disclosed press release since the information is not regarded as insider information. The MAR-label has therefore been removed from the press release. COPENHAGEN, Denmark, 12 April 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that The Board of Directors and the Chief Executive Officer of DanCann Pharma publishes the annual report of the year 2021. The annual report is available after today's trading on the Spotlight Stock Market, and hereby available in this press release